Literature DB >> 15748780

Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease.

Nobuto Shibata1, Tohru Ohnuma, Shinji Higashi, Chie Usui, Taku Ohkubo, Akiyoshi Kitajima, Akira Ueki, Masatsugu Nagao, Heii Arai.   

Abstract

Recent studies suggested that matrix metalloproteinases (MMPs) might play an important role in the pathophysiology of Alzheimer's disease (AD). MMP-9 and MMP-3 are reported to degrade amyloid beta and have several functional polymorphisms associated with other common diseases. Four common polymorphisms in each of MMP-9 and MMP-3 were examined in AD cases and normal control individuals. Common polymorphisms of MMP-9, rs3918248, rs2664538, rs2250889 and rs2274756 showed no association with risk for AD. We observed strong linkage disequilibrium (LD) between rs2664538 and rs2250889 in our Japanese samples. The polymorphisms of MMP-3; 5A/6A insertion polymorphism in the promoter, rs3025079, rs520540 and rs679620 also did not influence risk for AD. LD of the 5A/6A polymorphism with rs679620 was relatively strong. These results suggest that the common polymorphisms of MMP-9 and MMP-3 investigated here are not associated with AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15748780     DOI: 10.1016/j.neurobiolaging.2004.09.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  8 in total

Review 1.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

2.  Matrix metalloproteinase-9 regulates survival of neurons in newborn hippocampus.

Authors:  Sachiko Murase; Ronald D McKay
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

3.  Intrathecal administration of naringenin improves motor dysfunction and neuropathic pain following compression spinal cord injury in rats: relevance to its antioxidant and anti-inflammatory activities.

Authors:  Sajad Fakhri; Shahryar Sabouri; Amir Kiani; Mohammad Hosein Farzaei; Khodabakhsh Rashidi; Ahmad Mohammadi-Farani; Ehsan Mohammadi-Noori; Fatemeh Abbaszadeh
Journal:  Korean J Pain       Date:  2022-07-01

4.  Matrix metalloproteinase (MMP)-3 polymorphism in patients with HBV related chronic liver disease.

Authors:  Hyun Phil Shin; Joung Il Lee; Joo-Ho Jung; Sung-Vin Yim; Hyun Jeong Kim; Jae Myung Cha; Jong Beom Park; Kwang Ro Joo; Jae Seok Hwang; Byoung-Kuk Jang
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

5.  Matrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected females.

Authors:  Yi-Chun Yeh; Hsiu-Chi Cheng; Wei-Lun Chang; Hsiao-Bai Yang; Bor-Shyang Sheu
Journal:  BMC Microbiol       Date:  2010-08-13       Impact factor: 3.605

6.  Matrix metalloproteinase-9 genetic variation and primary angle closure glaucoma in a Caucasian population.

Authors:  Mona S Awadalla; Kathryn P Burdon; Abraham Kuot; Alex W Hewitt; Jamie E Craig
Journal:  Mol Vis       Date:  2011-05-27       Impact factor: 2.367

7.  Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients.

Authors:  Vladimira Durmanova; Juraj Javor; Zuzana Parnicka; Gabriel Minarik; Agata Ocenasova; Barbora Vaseckova; Veronika Reznakova; Maria Kralova; Tomas Hromadka; Ivana Shawkatova
Journal:  Mediators Inflamm       Date:  2021-04-19       Impact factor: 4.711

8.  MMP-3 gene polymorphisms are associated with increased risk of osteoarthritis in Chinese men.

Authors:  Wen Guo; Pengcheng Xu; Tianbo Jin; Jihong Wang; Dongsheng Fan; Zengtao Hao; Yuntao Ji; Shangfei Jing; Chaoqian Han; Jieli Du; Dong Jiang; Shuzheng Wen; Jianzhong Wang
Journal:  Oncotarget       Date:  2017-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.